Neural Drug Delivery Fluidic Threads with Electroactive Polymer Gates
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current neural drug delivery systems for treating brain tumors, such as malignant glioblastoma multiforme, face challenges in overcoming complex tumor morphologies and achieving precise control of drug delivery due to limitations in catheter technology and mass transport characteristics, leading to inadequate targeting and potential damage to healthy tissue.
Innovation Solution
A neural drug delivery system featuring implantable fluidic threads with electroactive polymer port gates that can be selectively opened or closed using conductive signals, allowing for adjustable pressure-driven infusion and precise control of drug delivery, including gradient open modes for fine-tuned flow rates, and integrated sensors for feedback control and tissue impedance measurement.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If conventional catheters are used for convection-enhanced delivery, then drug delivery to brain tumors is achieved, but precise control of drug concentrations over time and space is not possible
Solution Approach 1:
The catheter is divided into multiple independently controllable segments or zones, each capable of delivering drug at different concentrations and rates. This segmentation enables precise spatial control of drug distribution while maintaining manageable system complexity through modular design
Solution Approach 2:
The catheter incorporates dynamically adjustable parameters including variable infusion rates, controllable pressure gradients, and adjustable port gate openings. These dynamic controls allow real-time optimization of drug concentration delivery to match tumor heterogeneity and treatment requirements
2Reliability
If pressure-driven infusion is used to overcome blood-brain barrier, then direct delivery to interstitial space is achieved, but control over drug distribution in complex tumor morphologies is insufficient
Solution Approach 1:
The catheter system provides locally optimized delivery parameters at different positions along the catheter length, with each region capable of independent pressure control and infusion rate adjustment. This enables tailored drug distribution to match local tumor characteristics and heterogeneity
Solution Approach 2:
The system incorporates sensors that monitor pressure, flow rate, and drug concentration in real-time, providing feedback to a control system that automatically adjusts infusion parameters. This closed-loop control ensures reliable delivery while adapting to complex tumor morphology and hydrostatic characteristics
3Productivity
If current injection methods are used, then drug delivery is achieved, but precise targeting is not possible leading to potential damage to healthy tissue
Solution Approach 1:
The catheter incorporates multiple independently controllable ports or injection sites along its length, allowing selective delivery to specific tumor regions while avoiding healthy tissue. Each port can be activated independently based on real-time imaging and tumor mapping
Solution Approach 2:
The system uses dynamically adjustable pressure gradients and infusion rates that can be optimized for each injection site. This dynamic control enables precise targeting by adjusting flow parameters to match the specific anatomical and physiological characteristics of each tumor region
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
Enables precise, scalable, and programmable direct delivery of chemotherapeutic agents to brain tumors, optimizing treatment while minimizing adverse effects on healthy tissue, and supporting clinical therapy with improved control over drug distribution and localization.
Implementation Method 1
each port gate includes a thin-film mesh structure that is coupled to a corresponding fluid delivery port and at least partially coated with an electroactive polymer, in which each port gate is selectively operable between a closed mode and an open mode in response of the electroactive polymer to a conductive signal
Data Source
AI summary
A neural drug delivery system with fluidic threads implantable into tissue, including: a plurality of fluid delivery conduits configured to transport fluid and having an array of fluid delivery ports through which the fluid is selectively released; a plurality of port gates each including a mesh structure coupled to a corresponding fluid delivery port and coated with an electroactive polymer; a voltage source providing a conductive signal; and an interconnect network that carries the conductive signal to the port gates. In response of the electroactive polymer to the conductive signal, each port gate is selectively operable between a closed mode that prevents transfer of fluid through its corresponding fluid delivery port to the tissue, and an open mode that allows transfer of the fluid through its corresponding fluid delivery port to the tissue.